Genetron Health

Specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment.

Launch date

2013

Employees

Market cap

Enterprise valuation

$103m (Public information from Mar 2024)

Beijing China (HQ)

http://www.genetronhealth.com/

https://www.linkedin.com/company/genetronhealth

Revenues, earnings & profits over time

CNY	2017	2018	2019	2020	2021	2022	2023
Revenues	109m	248m	323m	424m	532m	651m	765m
% growth	-	127 %	31 %	31 %	25 %	22 %	18 %
EBITDA	(431m)	(233m)	(626m)	(3.0b)	(460m)	(546m)	-
% EBITDA margin	(395 %)	(94 %)	(193 %)	(718 %)	(87 %)	(84 %)	-
Profit	(453m)	(512m)	(676m)	(3.1b)	(496m)	(808m)	-
% profit margin	(416 %)	(207 %)	(209 %)	(723 %)	(93 %)	(124 %)	-
R&D budget	49.3m	78.6m	91.7m	149m	254m	290m	-
R&D % of revenue	45 %	32 %	28 %	35 %	48 %	45 %	-

Date	Investors	Amount	Round
Sep 2015*	Origene Technologies Share Capital	CNY50.0m	Series A
Sep 2016	New Horizon Capital Zhongyuan Union Cell & Gene Eng Share Capital	N/A	Series B
Jan 2018	N/A	N/A	Series C
Nov 2019	Vivo Capital Alexandria Venture Investments Highlight Capital	$71.0m	Series D
Jun 2020	N/A	N/A	IPO
Total Funding		$77.9m

Tech stackLearn more about the technologies and tools that this company uses.

Hangzhou ImmuQuad(艾沐蒽) Biotech, LLC.

Genetron New Co

ACQUISITION by Genetron Health Oct 2023